<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00708032</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0806</org_study_id>
    <nct_id>NCT00708032</nct_id>
  </id_info>
  <brief_title>Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.</brief_title>
  <official_title>Clinical Performance of a New Daily Disposable Contact Lens Worn in a Neophyte Population.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Manchester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to evaluate the impact of wearing a new daily disposable soft contact lens
      on the neophyte population.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Papillary Conjunctivitis</measure>
    <time_frame>12 months</time_frame>
    <description>Papillary conjunctivitis which is collected as part of the biomicroscopy data and is identified from a slit lamp examination. Grade 0 to Grade 4 with grade 0 implying no health concerns.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biomicroscopy Findings After 12 Months of Daily Wear From Slit Lamp Analysis.</measure>
    <time_frame>at 12 months</time_frame>
    <description>Comprised of 8 categories (conjunctival hyperemia, limbal hyperemia, corneal vascularization, microcysts, Oedema, corneal staining, conjunctival staining and papillary conjunctivitis) each scored on a scale of 0 to 4 where 0=none, and 4=maximum score for each category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Acuity After 12 Months of Wear</measure>
    <time_frame>at 12 months</time_frame>
    <description>Visual acuity is measured at high and low contrasts, via the Snellen scale which is then mathematically converted to logMar units. High contrast refers to a darker print on the Snellen chart and is an easier testing environment compared to the low contrast which has a grayer print.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Overall Comfort After 12 Months of Daily Wear</measure>
    <time_frame>at 12 months</time_frame>
    <description>subject response using a scale of 0 to 100, where 0 = poor comfort, 100 = excellent comfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Overall Vision After 12 Months of Daily Wear</measure>
    <time_frame>at 12 months</time_frame>
    <description>subject response using a scale of 0 to 100, where 0 = poor vision, 100 = excellent vision</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Refractive Error</condition>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>spectacles</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>habitual spectacles worn daily for 12 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>narafilcon A soft contact lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>spectacles</intervention_name>
    <description>habitual spectacles</description>
    <arm_group_label>spectacles</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>narafilcon A soft contact lenses</intervention_name>
    <description>narafilcon A daily disposable contact lenses</description>
    <arm_group_label>narafilcon A soft contact lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. They are of legal age (18 years) and capacity to volunteer.

          2. They understand their rights as a research subject and are willing to sign a Statement
             of Informed Consent.

          3. They are willing and able to follow the protocol.

          4. They would be expected to attain at least 6/9 (20/30) in each eye with the study
             lenses.

          5. They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.

          6. They have a maximum of 1.00D of refractive astigmatism (i.e. â‰¤ 1.00 DC).

          7. They have successfully worn contact lenses within six months of starting the study.

        Exclusion Criteria:

          1. They have an ocular disorder which would normally contra-indicate contact lens wear.

          2. They have a systemic disorder which would normally contra-indicate contact lens wear.

          3. They are using any topical medication such as eye drops or ointment.

          4. They are aphakic.

          5. They have had corneal refractive surgery.

          6. They have any corneal distortion resulting from previous hard or rigid lens wear or
             has keratoconus.

          7. They are pregnant or lactating.

          8. They have grade 2 or greater of any of the following ocular surface signs: corneal
             oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any
             other abnormality which would normally contraindicate contact lens wear.

          9. They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease
             (e.g. HIV).

         10. They have diabetes.

         11. They have taken part in any other clinical trial or research, within two weeks prior
             to starting this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Eurolens Research, The University of Manchester</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M60 1QD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2008</study_first_submitted>
  <study_first_submitted_qc>June 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2008</study_first_posted>
  <results_first_submitted>November 3, 2011</results_first_submitted>
  <results_first_submitted_qc>November 3, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 8, 2011</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>There were 74 subjects enrolled into the study, 38 into the TruEye group and 36 in the spectacle group. Forty-eight subjects completed the study.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Spectacles</title>
          <description>spectacles worn daily for 12 months</description>
        </group>
        <group group_id="P2">
          <title>Narafilcon A Lenses</title>
          <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Poor vision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Visit out of range at month 12</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not meet protocol criteria</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There were 74 subjects enrolled with 48 completing the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Spectacles</title>
          <description>spectacles worn daily for 12 months</description>
        </group>
        <group group_id="B2">
          <title>Narafilcon A Lenses</title>
          <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="74"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.5" spread="8.1"/>
                    <measurement group_id="B2" value="26.5" spread="7.4"/>
                    <measurement group_id="B3" value="26.5" spread="7.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Secondary</type>
        <title>Biomicroscopy Findings After 12 Months of Daily Wear From Slit Lamp Analysis.</title>
        <description>Comprised of 8 categories (conjunctival hyperemia, limbal hyperemia, corneal vascularization, microcysts, Oedema, corneal staining, conjunctival staining and papillary conjunctivitis) each scored on a scale of 0 to 4 where 0=none, and 4=maximum score for each category.</description>
        <time_frame>at 12 months</time_frame>
        <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A Lenses</title>
            <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>habitual spectacles worn daily for 12 months</description>
          </group>
        </group_list>
        <measure>
          <title>Biomicroscopy Findings After 12 Months of Daily Wear From Slit Lamp Analysis.</title>
          <description>Comprised of 8 categories (conjunctival hyperemia, limbal hyperemia, corneal vascularization, microcysts, Oedema, corneal staining, conjunctival staining and papillary conjunctivitis) each scored on a scale of 0 to 4 where 0=none, and 4=maximum score for each category.</description>
          <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Conjunctival Hyperemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.09" spread="0.22"/>
                    <measurement group_id="O2" value="1.00" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Limbal Hyperemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.89" spread="0.25"/>
                    <measurement group_id="O2" value="0.80" spread="0.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corneal Vascularization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Microcysts</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Oedema</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.00"/>
                    <measurement group_id="O2" value="0.00" spread="0.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Corneal Staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.33" spread="0.32"/>
                    <measurement group_id="O2" value="0.25" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Conjunctival Staining</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.83" spread="0.40"/>
                    <measurement group_id="O2" value="0.22" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Acuity After 12 Months of Wear</title>
        <description>Visual acuity is measured at high and low contrasts, via the Snellen scale which is then mathematically converted to logMar units. High contrast refers to a darker print on the Snellen chart and is an easier testing environment compared to the low contrast which has a grayer print.</description>
        <time_frame>at 12 months</time_frame>
        <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A Lenses</title>
            <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>habitual spectacles worn daily for 12 months</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Acuity After 12 Months of Wear</title>
          <description>Visual acuity is measured at high and low contrasts, via the Snellen scale which is then mathematically converted to logMar units. High contrast refers to a darker print on the Snellen chart and is an easier testing environment compared to the low contrast which has a grayer print.</description>
          <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>logMar</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>High Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.05" spread="0.08"/>
                    <measurement group_id="O2" value="-0.11" spread="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low Contrast</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.29" spread="0.11"/>
                    <measurement group_id="O2" value="0.18" spread="0.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Overall Comfort After 12 Months of Daily Wear</title>
        <description>subject response using a scale of 0 to 100, where 0 = poor comfort, 100 = excellent comfort</description>
        <time_frame>at 12 months</time_frame>
        <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A Lenses</title>
            <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>habitual spectacles worn daily for 12 months</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Overall Comfort After 12 Months of Daily Wear</title>
          <description>subject response using a scale of 0 to 100, where 0 = poor comfort, 100 = excellent comfort</description>
          <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8" spread="10.0"/>
                    <measurement group_id="O2" value="82.2" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Overall Vision After 12 Months of Daily Wear</title>
        <description>subject response using a scale of 0 to 100, where 0 = poor vision, 100 = excellent vision</description>
        <time_frame>at 12 months</time_frame>
        <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A Lenses</title>
            <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>habitual spectacles worn daily for 12 months</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Overall Vision After 12 Months of Daily Wear</title>
          <description>subject response using a scale of 0 to 100, where 0 = poor vision, 100 = excellent vision</description>
          <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.7" spread="11.5"/>
                    <measurement group_id="O2" value="82.5" spread="15.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Papillary Conjunctivitis</title>
        <description>Papillary conjunctivitis which is collected as part of the biomicroscopy data and is identified from a slit lamp examination. Grade 0 to Grade 4 with grade 0 implying no health concerns.</description>
        <time_frame>12 months</time_frame>
        <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
        <group_list>
          <group group_id="O1">
            <title>Narafilcon A Lenses</title>
            <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
          </group>
          <group group_id="O2">
            <title>Spectacles</title>
            <description>habitual spectacles worn daily for 12 months</description>
          </group>
        </group_list>
        <measure>
          <title>Papillary Conjunctivitis</title>
          <description>Papillary conjunctivitis which is collected as part of the biomicroscopy data and is identified from a slit lamp examination. Grade 0 to Grade 4 with grade 0 implying no health concerns.</description>
          <population>Subjects analyzed were those who were enrolled, randomized to a study arm, and completed the study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.22" spread="0.21"/>
                    <measurement group_id="O2" value="1.04" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Spectacles</title>
          <description>spectacles worn daily for 12 months</description>
        </group>
        <group group_id="E2">
          <title>Narafilcon A Lenses</title>
          <description>narafilcon A soft contact lenses worn as daily disposable for 12 months</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>CLPU</sub_title>
                <description>Contact Lens Related Peripheral Ulcer</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Car accident</sub_title>
                <assessment>Non-systematic Assessment</assessment>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Corneal Staining</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="38"/>
              </event>
              <event>
                <sub_title>Slitlamp findings</sub_title>
                <description>grade 3 or higher finding</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Publication requires agreement and written consent from the Sponsor.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kathy Osborn, OD</name_or_title>
      <organization>Johnson &amp; Johnson Vision Care, Inc.</organization>
      <phone>+1 904 443-1032</phone>
      <email>clinicalstudies@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

